3 medicines held by GlaxoSmithKline Biologicals on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Arexvy powder and suspension for suspension for injection Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted) EU/1/23/1740/001-002 |
Recombinant respiratory syncytial virus pre-fusion F protein, adjuvanted with AS01E | GlaxoSmithKline Biologicals | — |
| Infanrix hexa EU/1/00/152/005 |
Pertactin, Pertussis toxoid, Hbs ag, Diphtheria toxoid, Filamentous haemagglutinin | GlaxoSmithKline Biologicals | — |
| Infanrix hexa EU/1/00/152/012 |
Haemophilus influenzae, Pertactin, Diphtheria toxoid, Polysaccharide-k, Tetanus toxoid | GlaxoSmithKline Biologicals | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 6 July 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.